HCA Healthcare stock
Price history
+5.36% over the period1 year: from $477.10 (November 17, 2025) to $502.67 (November 17, 2026), +5.36%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | $502.67 |
| October 30, 2026 | $473.19 |
| September 30, 2026 | $426.74 |
| August 31, 2026 | $414.45 |
| July 31, 2026 | $402.59 |
| June 30, 2026 | $389.89 |
| May 29, 2026 | $378.54 |
| April 30, 2026 | $434.45 |
| March 31, 2026 | $473.24 |
| February 27, 2026 | $529.70 |
| January 30, 2026 | $488.27 |
| December 31, 2025 | $466.86 |
| November 28, 2025 | $508.29 |
| November 17, 2025 | $477.10 |
At a glance
The company
Owns and operates hospitals, surgical centers, emergency care facilities and other healthcare providers across the United States
Latest results
Quarter to September 30, 2026 · EPS $7.22 (estimate $6.65)
Next event
Dividend
TickerLandia's take on HCA Healthcare
- Pricier than usual relative to earnings: P/E on the latest fiscal year 18 vs a median of 14 over its last 10 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 17 vs 17 (−1%) in a group of 11.
- Strong point: Earnings stability (78/100 in its group). Weak point: Growth (34/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−9.94% from the 52-week high
Analysts · 26 analysts
Average target$483.41−3.55% vs. price
Buy 15 · Hold 9 · Sell 2 · Buy
TickerLandia Fingerprint: HCA Healthcare
Compared with similar companies: high earnings stability, strong momentum, and high profitability.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 883 North American stocks.
Priceaverage43
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 17.0 36 Forward P/E 16.3 53 EV/EBITDA 10.2 34 Price/sales 1.36 50 Profitabilityhigh70
How much it earns on revenue and capital.
Metric Value Position in group ROA 12.2% 97 Operating margin 15.3% 55 Gross margin 42.8% 66 Net margin 8.6% 61 Earnings stabilityhigh78
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.7% 97 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 58 Growthlow34
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +7.87% 34 Earnings growth (year over year) +4.50% 45 Revenue growth (year over year) +3.60% 24 Financial strengthlow38
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 5.32 45 Net debt/EBITDAcounts in reverse: lower means more financial strength 2.93 45 Current ratio 0.82 24 Dividendlow36
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 9 years 50 Dividend yield 0.6% 38 Payout ratio 10.1% 21 Market momentumstrong74
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +29.24% 97 Relative strength (6 months) +18.36% 77 1-year return +5.05% 40 Distance from 200-day average +12.51% 82 Riskaverage45
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 33.7% 61 Volatility (60 days) 33.0% 45 Beta (1 year) 0.23 28
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
HCA Healthcare is pricier than in the past and in line with similar companies
On the latest fiscal year's earnings (2025), HCA Healthcare's P/E today is 17.7, above the median of its last 10 fiscal years (14.0; between 10.1 and 16.5 from 2016 to 2025). HCA Healthcare's P/E (trailing 12 months): 17.0, in line with the median of a group of 11 similar companies (17.2).
Compared with 11 similar companies
| Metric | HCA Healthcare | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 17.0 | Middle | |
| Forward P/E | 16.3 | Middle | |
| Operating margin | 15.3% | Middle | |
| EV/EBITDA | 10.2 | Middle | |
| Net margin | 8.6% | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: HCA Healthcare. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$19.85B
Latest quarter · Q3 2026
Net income
$1.58B
Latest quarter · Q3 2026
Quarterly net margin
8.0%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $106.91B
- P/E
- 17.0
- EPS
- $30.15
- Volume
- 1.05M
- Daily trading
- €622.61M
- Dividend yield
- 0.61%
How HCA Healthcare is changing
All resultsRevenue grew 8.0% a year on average over the last 5 years
Profits turn into cash: free cash flow equal to 101% of net income
Shares outstanding down 30.3% in 5 years
Returns
HCA Healthcare returns with dividends
$1,000 invested in HCA Healthcare 5 years ago, on November 17, 2021, would be worth $2,149 today with dividends reinvested: +114.87% in total, +16.53% per year. On price alone it would be $2,061 (+106.13%).
| Period | HCA Healthcare | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +10.51% | −3.17% | $1,105 |
| 6 months | +18.48% | +0.11% | $1,185 |
| Year to date | +7.67% | +8.34% | $1,077 |
| 1 year | +6.08% | +11.15% | $1,061 |
| 3 years | +108.71% | +64.30% | $2,087 |
| 5 years | +114.87% | +58.18% | $2,149 |
| 10 years | +628.04% | +239.10% | $7,280 |
Over the last 6 months it has done better than 54% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
HCA Healthcare: technical analysis
HCA Healthcare is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 8.1% below its all-time closing high ($545.13, March 9, 2026).
- Trend
- Upward
- RSI (14 sessions)
- 60
- Between 30 and 70
- vs 200-session average
- +12.51%
Active signals
Golden cross: the 50-session average has crossed above the 200-session average.
since November 9, 2026
Support and resistance
Price areas where HCA Healthcare has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$552.28+10.19%3 touches, last on March 12, 2026
- Resistance$522.71+4.29%5 touches, last on November 5, 2026
- Last price$501.19
- Support$487.90−2.65%3 touches, last on October 27, 2026
- Support$478.88−4.45%2 touches, last on October 15, 2026
- Support$461.11−8.00%4 touches, last on April 2, 2026
Volatility and risk
Over the last year it has moved little with the S&P 500.
- Beta (1 year) vs S&P 500
- 0.23
- Volatility (60 sessions, annualised)
- 33.0%
- Largest fall in the last year
- −33.72%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
HCA Healthcare: seasonality
Average monthly price change over 16 years
Over the last 16 years, the strongest month for HCA Healthcare has been January: +6.38% on average, positive in 11 years out of 15. The weakest has been April: +0.23% on average, positive in 5 years out of 16. November, the current month, has been positive in 9 years out of 15 (+4.23% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +6.38% | +6.30% | 11 of 15 |
| February | +1.14% | +1.05% | 8 of 15 |
| March | +0.94% | +2.54% | 10 of 15 |
| April | +0.23% | −1.46% | 5 of 16 |
| May | +0.72% | −2.01% | 7 of 16 |
| June | +1.09% | −0.04% | 8 of 16 |
| July | +5.13% | +2.89% | 10 of 16 |
| August | +0.29% | +1.79% | 9 of 16 |
| September | +0.32% | +0.83% | 11 of 16 |
| October | +1.45% | +0.30% | 8 of 16 |
| November | +4.23% | +3.97% | 9 of 15 |
| December | +0.57% | +2.78% | 8 of 15 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
HCA Healthcare and its competitors
Hospitals, emergency rooms, urgent care and walk-in clinics are the facilities most patients associate with HCA Healthcare, Inc. Through its subsidiaries, the company runs a network across the United States that also includes ambulatory surgery centers, diagnostic and imaging centers, radiation and oncology therapy centers, and rehabilitation and physical therapy centers. Its general and acute care hospitals provide inpatient and intensive care, cardiac care, surgery, laboratory and radiology services, and emergency care, while physician practices, home health agencies and hospices extend care beyond the hospital walls.
- Headquarters
- Nashville, United States
- Employees
- 230,000
- Founded
- 1968
- Chief executive
- Samuel Hazen
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| HCA HealthcareHCA | $106.91B | 15.3% | 17.0 | +18.48% |
| Tenet HealthcareTHC | $23.2B | 19.1% | 8.53 | +43.43% |
| Encompass HealthEHC | $13.63B | 18.4% | 22.2 | +29.29% |
| Universal Health ServicesUHS | $11.4B | 10.9% | 8.28 | +13.84% |
| DavitaDVA | $10.96B | 15.2% | 13.2 | −13.39% |
| Ensign GroupENSG | $10.59B | 8.6% | 28.9 | +4.70% |
Same industry or related industries, similar size. Compare HCA Healthcare with its competitors · Full profile
